Semaglutide Pharmacokinetics in American Males: Absorption, Distribution, and Clinical Implications
Reading Time: 2 minutes Introduction to Semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a pivotal treatment for type 2 diabetes and obesity among American males. Its efficacy in managing blood glucose levels and promoting weight loss has sparked interest in understanding its pharmacokinetics, particularly what occurs after its administration. Absorption and Bioavailability Following subcutaneous injection, semaglutide's absorption is a gradual process. It reaches peak plasma concentrations approximately 1 to 3 days post-injection. The bioavailability of semaglutide is approximately 89%, indicating that a significant portion of the administered dose is effectively absorbed into the systemic circulation. This high bioavailability is crucial...


